The Signal Directory

HealthTech executives worth following

Founders, investors, health system and payer leaders, policy people and analysts. Filter by the part of the industry they work in and where they post.

Looking for practising clinicians instead? Open the clinician directory.

EB

Eugene Borukhovich

Digital Therapeutics

Co-founder and Chief Operating Officer, YourCoach Health

Eugene hosts discussions and posts extensively about the digital health ecosystem, including how digital coaching and digital therapeutics intersect to improve patient outcomes.

Digital Health coaching / Health Tech Startups / DTx Integration

Best for: Healthcare entrepreneurs and digital coaches

SL

Shaheen Lakhan, MD, PhD

Digital Therapeutics

Chief Medical Officer, Click Therapeutics

Dr. Lakhan shares clinical perspectives on the intersection of neurology, psychiatry, and software-driven medical interventions. He details how digital therapeutics are validated and prescribed.

Neurotherapeutics / Digital Medicine / Clinical Trials

Best for: Clinicians and clinical trial managers

AM

Andy Molnar

Digital Therapeutics

Chief Executive Officer, Digital Therapeutics Alliance

He provides regular updates on digital therapeutics legislation, payer coverage decisions, and efforts to integrate clinically validated software into mainstream healthcare.

DTx Advocacy / Healthcare Policy / Market Access

Best for: Market access leads and digital health founders

AI

Anand Iyer, PhD

Digital Therapeutics

Chief Digital Officer, Welldoc

Anand offers valuable strategies for scaling digital therapeutic solutions for chronic diseases, focusing on clinical integration, patient engagement, and reimbursement models.

Chronic Disease Management / Digital Health / DTx Commercialization

Best for: Digital health product leaders and health system executives

MC

Marty Culjat, PhD

Digital Therapeutics

SVP of Digital Medicine and DTx, EVERSANA

Marty shares practical advice on how to commercialize digital therapeutics, navigate regulatory hurdles, and gain clinical adoption from providers.

Commercialization / Medical Affairs / Regulatory Strategy

Best for: Regulatory affairs professionals and commercial teams

MC

Megan Coder, PharmD

Digital Therapeutics

Chief Policy Officer, Digital Therapeutics Alliance

Readers gain deep insights into global regulatory pathways, reimbursement policies, and clinical evidence standards shaping the digital therapeutics industry.

Digital Therapeutics Policy / DTx Regulation / Global Market Access

Best for: DTx executives and regulatory policy experts

JS

Jessica Shull, PhD

Digital Therapeutics

Digital Health Advisor and Researcher, VictoRx

She provides a critical European perspective on digital therapeutics, analyzing policies like Germany's DiGA and France's PECAN reimbursement frameworks.

European Regulation / DTx Reimbursement / Global Health Technology

Best for: European digital health developers and policy analysts

AL

Amir Lahav, ScD

Digital Therapeutics

Digital Health and DTx Advisor, Lahav Consulting

Amir shares expert analysis on clinical evidence generation, pharma collaboration with DTx companies, and the translation of digital biomarkers into clinical trials.

Digital Medicine / Pharma Partnerships / Clinical Development

Best for: Pharma innovators and digital medicine researchers

OM

Owen McCarthy

Digital Therapeutics

Co-founder and President, MedRhythms

Follow Owen for insights on developing prescription digital therapeutics that use music and technology to improve walking and rehabilitation in neurologic populations.

Neurorehabilitation / Digital Therapeutics / Entrepreneurship

Best for: Medtech entrepreneurs and rehabilitation specialists

DP

Dmitry Popolov

Digital Therapeutics

Digital Therapeutics Analyst, Independent Consultant

Dmitry curates comprehensive global updates on digital therapeutic regulatory approvals, funding rounds, and clinical trial results, saving followers hours of research.

DTx Market Intelligence / Regulatory Frameworks / Industry Trends

Best for: Industry researchers and venture capital analysts

Showing 10 of 190 people. Listings are editorial, not paid, and nobody pays to appear here.